Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agios Pharmaceuticals (AGIO) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Agios Pharmaceuticals (AGIO) over the last 10 years, with Q3 2025 value amounting to -$1.78.

  • Agios Pharmaceuticals' EPS (Weighted Average and Diluted) fell 11097.41% to -$1.78 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0, marking a year-over-year decrease of 16161.97%. This contributed to the annual value of $11.64 for FY2024, which is 28385.73% up from last year.
  • As of Q3 2025, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$1.78, which was down 11097.41% from -$1.93 recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $26.95 during Q1 2021, and registered a low of -$1.93 during Q2 2025.
  • For the 5-year period, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around $1.03, with its median value being -$1.55 (2025).
  • As far as peak fluctuations go, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) skyrocketed by 411093.75% in 2021, and later crashed by 35671.64% in 2023.
  • Over the past 5 years, Agios Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at $0.07 in 2021, then skyrocketed by 923.5% to $0.67 in 2022, then tumbled by 356.72% to -$1.72 in 2023, then rose by 3.06% to -$1.67 in 2024, then decreased by 6.75% to -$1.78 in 2025.
  • Its last three reported values are -$1.78 in Q3 2025, -$1.93 for Q2 2025, and -$1.55 during Q1 2025.